Universal Biosensors, Inc. UBI-Financial and Strategic SWOT Analysis Review

Universal Biosensors, Inc. UBI-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDME7173FSA
  • |
  • Pages: 39
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Universal Biosensors, Inc. (UBI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Universal Biosensors, Inc. (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI's major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia.

Universal Biosensors, Inc. Key Recent Developments

Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director

Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Universal Biosensors, Inc.-Key Facts 6

Universal Biosensors, Inc.-Key Employees 7

Universal Biosensors, Inc.-Key Employee Biographies 8

Universal Biosensors, Inc.-Major Products and Services 9

Universal Biosensors, Inc.-Medical Equipment Pipeline Products Data 10

Universal Biosensors, Inc. Pipeline Products by Equipment Type 10

Universal Biosensors, Inc. Pipeline Products by Development Stage 12

Universal Biosensors, Inc.-History 13

Universal Biosensors, Inc.-Company Statement 16

Universal Biosensors, Inc.-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 18

Universal Biosensors, Inc.-Business Description 18

Universal Biosensors, Inc.-Corporate Strategy 19

Universal Biosensors, Inc.-SWOT Analysis 20

SWOT Analysis-Overview 20

Universal Biosensors, Inc.-Strengths 20

Strength-Research and Development Activities 20

Strength-Novel Strip and Meter Technologies 20

Strength-Strategic Alliances and Partnerships 20

Universal Biosensors, Inc.-Weaknesses 21

Weakness-Operating Loss Carryforward 21

Weakness-Declining Cash Reserves 21

Universal Biosensors, Inc.-Opportunities 22

Opportunity-Growing Point-of-Care Testing Market 22

Opportunity-Growing Diabetes Care Devices Market 22

Opportunity-Growth in Emerging Economies 22

Universal Biosensors, Inc.-Threats 23

Threat-Single Manufacturing Facility 23

Threat-Risk of Product Obsolescence 23

Threat-Stiff Competition 23

Universal Biosensors, Inc.-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

Universal Biosensors, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 30

Universal Biosensors, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 31

Universal Biosensors, Inc., Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director 33

Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015 34

Section 6-Appendix 35

Methodology 35

Ratio Definitions 35

About GlobalData 39

Contact Us 39

Disclaimer 39

List of Figures

Universal Biosensors, Inc. Pipeline Products by Equipment Type 10

Universal Biosensors, Inc. Pipeline Products by Development Stage 12

Universal Biosensors, Inc., Performance Chart (2011-2015) 27

Universal Biosensors, Inc., Ratio Charts 29

Universal Biosensors, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 30

Universal Biosensors, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 31

List of Tables

Universal Biosensors, Inc., Key Facts 6

Universal Biosensors, Inc., Key Employees 7

Universal Biosensors, Inc., Key Employee Biographies 8

Universal Biosensors, Inc., Major Products and Services 9

Universal Biosensors, Inc. Number of Pipeline Products by Equipment Type 10

Universal Biosensors, Inc. Pipeline Products by Equipment Type 11

Universal Biosensors, Inc. Number of Pipeline Products by Development Stage 12

Universal Biosensors, Inc. Pipeline Products by Development Stage 12

Universal Biosensors, Inc., History 13

Universal Biosensors, Inc., Subsidiaries 17

Universal Biosensors, Inc., Key Competitors 24

Universal Biosensors, Inc., Ratios based on current share price 25

Universal Biosensors, Inc., Annual Ratios 26

Universal Biosensors, Inc., Interim Ratios 28

Universal Biosensors, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 30

Universal Biosensors, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 31

Universal Biosensors, Inc., Recent Deals Summary 32

Currency Codes 35

Capital Market Ratios 35

Equity Ratios 36

Profitability Ratios 36

Cost Ratios 37

Liquidity Ratios 37

Leverage Ratios 38

Efficiency Ratios 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Siemens Healthcare GmbH

Roche Diagnostics International Ltd.

Diagnostica Stago SAS

Beckman Coulter, Inc.

Bayer Corporation

Alere Inc.

Abbott Point of Care Inc.

Universal Biosensors, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8131
Site License
USD 250 INR 16263
Corporate User License
USD 375 INR 24394

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com